Electrical Cardiometry in Management of Acute Heart Failure

Not Applicable

Completed

• Conditions: Acute Heart Failure (AHF)

• Registration Number: NCT06982560
• Lead Sponsor: Alexandria University

Brief Summary

The goal of this clinical trial is to assess if electrical cardiometry (EC) could help in managing acute heart failure (AHF). The main questions it aims to answer are:

1. Is there effect of use of cardiometry on rate of use of vasopressors, vasodilators and inotropes?

2. is there effect of use of cardiometry on mortality and hospital length of stay?

Researchers compared cardiometry to traditional methods like clinical examination, lung ultrasound and inferior vena cava.

Participants were divided into two groups, one managed by cardiometry and the other by traditional methods, then followed till improvement or death and compared regarding use of medications, length of stay and mortality

Detailed Description

The purpose of the research is to assess the role of electrical cardiometry in hemodynamic monitoring in studied cases with acute heart failure to guide treatment.

This is a prospective controlled research that involved fifty patients, diagnosed with acute heart failure and admitted to critical care units at Alexandria University Hospitals, patients were divided into 2 groups:

Group A: was assessed by traditional methods which include: clinical examination including chest auscultation and systolic blood pressure measurement, lung ultrasound and inferior vena cava assessment and managed according to the results of these parameters.

Group B: was assessed by electrical cardiometry parameters as cardiac output, thoracic fluid content (TFC) and systemic vascular resistance (SVR) and was managed as following: inotropes up and down titration according to cardiac output readings, use of vasopressors or vasodilators according to SVR readings, doses of diuretics were modified according to TFC readings.

Study Timeline

• Study Start: 2023-12-01
• Primary Completion: 2024-11-30
• Study Completion: 2024-12-31
• Status Verified: 2025-05
• Study First Submitted: 2025-05-06
• Study First Submitted QC: 2025-05-18
• Last Update Submitted: 2025-05-18
• Study First Posted: 2025-05-21
• Last Update Posted: 2025-05-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• acute heart failure

Exclusion Criteria

• pregnant females, atrial fibrillation, severe valvular diseases, skin lesions in thoracic area, large pleural effusion

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
mortality and intensive care unit (ICU) length of stay	7 days	number of days in ICU and mortality in ICU

Secondary Outcome Measures

Name	Time	Method
use of vasopressors, vasodilators, inotropes	7 days	number of patients who needed these medications

Trial Locations

Locations (1)

Alexandria University Hospitals; 🇪🇬 Alexandria, Egypt